McARDLE DISEASE: P.115 Natural history of McArdle disease in a cohort of 220 patients

dc.contributor.authorQuinlivan, Ros
dc.contributor.authorPietrusz, A.
dc.contributor.authorPizzamiglio, Chiara
dc.contributor.authorPattni, J.
dc.contributor.authorMahroo, O.
dc.contributor.authorKhan, K.
dc.contributor.authorElliott, P.
dc.contributor.authorPatasin, M.
dc.contributor.authorLucía Mulas, Alejandro
dc.contributor.authorGodfrey, Richard
dc.contributor.authorEt al.
dc.date.accessioned2020-03-31T11:05:06Z
dc.date.available2020-03-31T11:05:06Z
dc.date.issued2019
dc.description.abstractMcArdle disease is caused by recessive mutations in the gene encoding muscle glycogen phosphorylase (MGP) which results in enzyme deficiency. The condition is considered to cause a 'pure' muscle phenotype with symptoms including: exercise intolerance, inability to perform isometric activities. Known associated complications include: hyperuricaemia and gout, acute rhabdomyolysis with myoglobinuria leading to compartment syndrome and acute renal failure. We retrospectively assessed case records of 220 patients with genetically confirmed McArdle disease from 2011-2019 and will report data relating to genotype, phenotype (including frequency of known associated complications) and functional capacity based upon a 12 minute walking test. We will also report results of prospective screening for other 'unexpected' co-morbidities in our cohort including the frequency of cardiovascular disease, thyroid disease and pattern retinal dystrophy. We also assessed the frequency of other systemic disorders. Our data suggest that MGP deficiency is not such a benign condition and may be associated with systemic issues beyond the skeletal muscles. The role of MGP in both skeletal and non-skeletal muscle tissues may give a clue as to the underlying pathogenesis of these co-morbidities. Prospective regular monitoring of these patients may be worthwhile.spa
dc.description.filiationUEMspa
dc.description.impact3.115 JCR (2019) Q3, 76/204 Clinical Neurologyspa
dc.description.impact1.177 SJR (2019) Q1, 85/378 Neurology (clinical)spa
dc.description.impactNo data IDR 2019spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationQuinlivan, R., Pietrusz, A., Pizzamiglio, C., Pattni, J., Mahroo, O., Khan, K., Elliott, P., Patasin, M., Chatfield, S., Lucía Mulas, A., Zugaza, J., Llavero, F., & Godfrey, R. (2019). McARDLE DISEASE: P.115 Natural history of McArdle disease in a cohort of 220 patients. Neuromuscular Disorders, 29(S1), S82. https://doi.org/10.1016/j.nmd.2019.06.171spa
dc.identifier.doi10.1016/j.nmd.2019.06.171
dc.identifier.issn0960-8966
dc.identifier.issn1873-2364
dc.identifier.urihttp://hdl.handle.net/11268/8885
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1016/j.nmd.2019.06.171spa
dc.rights.accessRightsopen accessspa
dc.subject.uemMetabolismospa
dc.subject.uemAparato circulatoriospa
dc.subject.uemEnfermedadesspa
dc.subject.unescoMetabolismospa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoGenética humanaspa
dc.titleMcARDLE DISEASE: P.115 Natural history of McArdle disease in a cohort of 220 patientsspa
dc.typeconference outputspa
dspace.entity.typePublication
relation.isAuthorOfPublicationd3691359-d7bd-4a12-b84e-338e28c81f9f
relation.isAuthorOfPublication.latestForDiscoveryd3691359-d7bd-4a12-b84e-338e28c81f9f

Files